Formulation optimization of solid dispersion of mosapride hydrochloride

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of pharmacal research

• Publication date

  2011-10-06

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1007/s12272-011-0908-3PMID 21975808
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mosapride

  2012cited by this paper
• Formulation of Sustained-Release Dosage Form of Verapamil Hydrochloride by Solid Dispersion Technique Using Eudragit RLPO or Kollidon®SR

  2009cited by this paper
• Tailoring the Release Rates of Fluconazole Using Solid Dispersions in Polymer Blends

  2008cited by this paper
• Preparation and Characterization of Metoprolol Controlled-Release Solid Dispersions

  2006cited by this paper
• Preparation of a solid dispersion of felodipine using a solvent wetting method.

  2006cited by this paper
• Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release.

  2006cited by this paper
• Adjusting drug diffusivity using miscible polymer blends.

  2005cited by this paper
• Preparation and characterization of blends of star-poly(epsilon-caprolactone-co-D,L-lactide) and oligo(epsilon-caprolactone).

  2005cited by this paper
• Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.

  2005cited by this paper
• Dissolution mechanism of poorly water-soluble drug from extended release solid dispersion system with ethylcellulose and hydroxypropylmethylcellulose.

  2005cited by this paper
• Compatibility Studies Between Ibuprofen or Ketoprofen with Cellulose Ether Polymer Mixtures Using Thermal Analysis

  2005cited by this paper
• Preparation and characterization of blends of star-poly(ε-caprolactone-co-D,L-lactide) and oligo(ε-caprolactone)

  2005cited by this paper
• Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.

  2004cited by this paper
• Controlled release of clozapine through chitosan microparticles prepared by a novel method.

  2004cited by this paper
• Once daily sustained release tablets of venlafaxine, a novel antidepressant.

  2002cited by this paper
• The mechanisms of drug release from solid dispersions in water-soluble polymers.

  2002cited by this paper
• Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25.

  2001cited by this paper
• Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol interpolymer complex with various cross-linking degrees of Carbopol.

  2000cited by this paper
• Control of medicine release from solid dispersion composed of the poly(ethylene oxide)-carboxyvinylpolymer interpolymer complex by varying molecular weight of poly(ethylene oxide).

  1999cited by this paper
• Physical Properties of Solid Molecular Dispersions of Indomethacin with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl-acetate) in Relation to Indomethacin Crystallization

  1999cited by this paper
• Spectroscopic Characterization of Interactions Between PVP and Indomethacin in Amorphous Molecular Dispersions

  1997cited by this paper
• Handbook of Pharmaceutical Excipients

  1994cited by this paper
• Pharmacokinetics of the gastrokinetic agent mosapride citrate after single and multiple oral administrations in healthy subjects.

  1993cited by this paper
• Mechanism of misoprostol stabilization in hydroxypropyl methylcellulose.

  1991cited by this paper
• Studies of interaction phenomena in aqueous-based film coatings containing soluble additives using thermal analysis techniques.

  1988cited by this paper
• Pharmaceutical applications of solid dispersion systems.

  1971cited by this paper
• Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man.

  1961cited by this paper

• Preparation and evaluation of valsartan orodispersible tablets using PVP-K30 and HPMC E3 solid dispersions by the solvent evaporation method

  2025cites this paper
• Kollidon® SR: Formulation techniques and drug delivery applications.

  2024cites this paper
• X-ray powder diffraction data for mosapride dihydrogen citrate dihydrate

  2024cites this paper
• An Intragastric Delivery Device Employing FDM Technology: 3D-Printed Tablet Containing Green Developed Mosapride-Saccharin Co-crystals

  2023cites this paper
• Formulation optimization of solid dispersion of candesartan cilexetil

  2023cites this paper
• Solid dispersion technology as a formulation strategy for the fabrication of modified release dosage forms: A comprehensive review

  2022cites this paper
• Formulation and Evaluation of Gliclazide Solid Dispersions Incorporated Tablets for Controlled Drug Release

  2020cites this paper
• Extruded filaments derived 3D printed medicated skin patch to mitigate destructive pulmonary tuberculosis: design to delivery

  2020cites this paper
• Effect of pirfenidone injection on ferret vocal fold scars: A preliminary in vivo study

  2020cites this paper
• Therapeutic Potential of Antileukotriene drug-Camellia sinensis extract co-formulation on Histamine induced Asthma in Guinea Pigs.

  2020cites this paper
• Pharmacokinetic analysis of mosapride following intravenous and oral administration in beagle dogs.

  2020cites this paper
• The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System

  2019cites this paper
• DEVELOPMENT AND EVALUATION OF VALSARTAN ORAL CONTROLLED RELEASE FORMULATIONS

  2018cites this paper
• Recent advances in pharmacological research on the management of irritable bowel syndrome

  2018cites this paper
• Fabrication of Hierarchical Polymeric Thin Films by Spin Coating Toward Production of Amorphous Solid Dispersion for Buccal Drug Delivery System: Preparation, Characterization, and In Vitro Release Investigations.

  2018cites this paper
• Engineering of a novel optimized platform for sublingual delivery with novel characterization tools: in vitro evaluation and in vivo pharmacokinetics study in human

  2017cites this paper
• "Solid Dispersion - a Novel Approach for Enhancement of Bioavailability of Poorly Soluble Drugs in Oral Drug Delivery System"

  2017cites this paper
• Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design

  2017cites this paper
• Pluronic F127 as a suitable carrier for preparing the imatinib base solid dispersions and its potential in development of a modified release dosage forms

  2017cites this paper
• THERMAL STABILITY ASSESMENT OF AMIODARONE HYDROCHLORIDE IN POLYMERIC MATRIX TABLETS

  2016cites this paper
• [Effect of EUDRAGIT® RS on the release behaviour of theophylline solid dispersions].

  2016cites this paper
• Development, characterization and solubility enhancement of comparative dissolution study of second generation of solid dispersions and microspheres for poorly water soluble drug

  2015cites this paper
• Controlled Release as a Strategy to Prevent Solution-mediated Phase Transformation in Amorphous Solid Dispersions: Effect of Dosage Form Design

  2014influential citation
• Solid dispersion tablets of breviscapine with polyvinylpyrrolidone K30 for improved dissolution and bioavailability to commercial breviscapine tablets in beagle dogs

  2013cites this paper
• A REVIEW ON ORAL CONTROL DRUG DELEVERY SYSTEM

  2013cites this paper
• Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system

  2012cites this paper
• A novel and alternative approach to controlled release drug delivery system based on solid dispersion technique

  2012cites this paper